Pharma - Shrine Yoga

Tavneos Approval Japan: The Worst Data Doubts Revealed

Tavneos approval Japan is under scrutiny due to data doubts. Find out what this means for patients and the pharmaceutical industry.

Anti-cancer drugs price control is a smart move by India to improve healthcare access.

Egyptian medicine prices may rise significantly in January 2027, impacting affordability and access for many citizens.

Pan-RAS inhibitor approval marks a significant milestone in cancer treatment.

Eli Lilly pharmaceutical plant is set to bring $3 billion investment to Katwijk, boosting the local economy and job market.

Drug prices patents are a major issue, as pharmaceutical companies pile up patents to maintain high costs.

Aar Shyam India acquisition has been approved, raising borrowing limits at AGM, signaling strong growth potential in the pharma sector.

Veterinary Pharmaceuticals Registration is crucial for compliance. Learn what to expect during the process in China.

FDA approval for OMCAZIO brings a proven solution to cancer treatment.

Sudarshan acquisition MedTherapy is a strategic decision that could reshape the biotech landscape.